REFERENCES
- Amirav, I., Balanov, I., Gorenberg, M., Groshar, D., and Luder, A. S. (2003). Nebuliser Hood Compared to Mask in Wheezy Infants: Aerosol Therapy without Tears! Arc. Dis. Child., 88:719–723.
- Amirav, I., Balanov, I., Gorenberg, M., Luder, A. S., Newhouse, M. T., and Groshar, D. (2002). Beta-Agonist Aerosol Distribution in Respiratory Syncytial Virus Bronchiolitis in Infants. J. Nucl. Med., 43:487–491.
- Asgharian, B., Kelly, J. T., and Tewksbury, E. W. (2003). Respiratory Deposition and Inhalability of Monodisperse Aerosols in Long-Evans Rats. Toxicol. Sci., 71:104–111.
- Berggren, E., Liljedahl, M., Winbladh, B., Andreasson, B., Curstedt, T., Robertson, B., and Schollin, J. (2000). Pilot Study of Nebulized Surfactant Therapy for Neonatal Respiratory Distress Syndrome. Acta. Paediatr., 89:460–464.
- Cowan, F., Whitelaw, A., Wertheim, D., and Silverman, M. (1991). Cerebral Blood Flow Velocity Changes after Rapid Administration of Surfactant. Arch. Dis. Child., 66:1105–1109.
- Dolovich, M. B. (2002). Assessing Nebulizer Performance. Respir. Care, 47:1290–1301; discussion 1301–1304.
- Farmaceutici, C. (2011). CUROSURF® (poractant alfa) Intratracheal Suspension Information. Chiesi Farmaceutici, Parma, Italy.
- Finer, N. N., Merritt, T. A., Bernstein, G., Job, L., Mazela, J., and Segal, R. (2010). An Open Label, Pilot Study of Aerosurf(R) Combined with nCPAP to Prevent RDS in Preterm Neonates. J. Aerosol. Med. Pulm. Drug. Deliv., 23:303–309.
- Fok, T. F., al-Essa, M., Dolovich, M., Rasid, F., and Kirpalani, H. (1998). Nebulisation of Surfactants in an Animal Model of Neonatal Respiratory Distress. Arch. Dis. Child. Fetal Neonatal. Ed., 78:F3–F9.
- Gunkel, J. H., and Banks, P. L. (1993). Surfactant Therapy and Intracranial Hemorrhage: Review of the Literature and Results of New Analyses. Pediatrics, 92:775–786.
- Halliday, H., and Robertson, B. (1992). Cerebral Blood Flow Velocity Changes after Rapid Administration of Surfactant. Arch. Dis. Child., 67:470.
- Harkins, W. D., and Humphrey, E. C. (1916). The Drop Weight Method for the Determination of Surface Tension. J. Am. Chem. Soc., 38:228–236.
- Jobe, A. H. (1993). Pulmonary Surfactant Therapy. New Engl. J. Med., 328:861–868.
- Jorch, G., Hartl, H., Roth, B., Kribs, A., Gortner, L., Schaible, T., Hennecke, K. H., and Poets, C. (1997). Surfactant Aerosol Treatment of Respiratory Distress Syndrome in Spontaneously Breathing Premature Infants. Pediatr. Pulmonol., 24:222–224.
- Lewis, J. F., Ikegami, M., Jobe, A. H., and Tabor, B. (1991). Aerosolized Surfactant Treatment of Preterm Lambs. J. Appl. Physiol., 70:869–876.
- Lewis, J. F., and McCaig, L. (1993). Aerosolized Versus Instilled Exogenous Surfactant in a Nonuniform Pattern of Lung Injury. Am. Rev. Respir. Dis., 148:1187–1193.
- Mazela, J., Merritt, T. A., and Finer, N. N. (2007). Aerosolized Surfactants. Curr. Opin. Pediatr., 19:155–162.
- Mazela, J., and Polin, R. A. (2011). Aerosol Delivery to Ventilated Newborn Infants: Historical Challenges and New Directions. Eur. J. Pediatr., 170:433–444.
- Mercier, C. E., and Soll, R. F. (1993). Clinical Trials of Natural Surfactant Extract in Respiratory Distress Syndrome. Clin. Perinatol., 20:711–735.
- Murgia, X., Gastiasoro, E., Mielgo, V., Alvarez-Diaz, F., Lafuente, H., Valls-i-Soler, A., Gomez-Solaetxe, M. A., Larrabe, J. L., and Rey-Santano, C. (2011). Surfactant and Perfluorocarbon Aerosolization by Means of Inhalation Catheters for the Treatment of Respiratory Distress Syndrome: An In Vitro Study. J. Aerosol. Med. Pulm. Drug. Deliv., 24:81–87.
- Raabe, O. G., Al-Bayati, M. A., Teague, S. V., and Rasolt, A. (1988). Regional Deposition of Inhaled Monodisperse Coarse and Fine Aerosol Particles in Small Laboratory Animals. Ann. Occup. Hyg., 32:53–63.
- Rodriguez, R. J., and Martin, R. J. (1999). Exogenous Surfactant Therapy in Newborns. Respir. Care Clin. N. Am., 5:595–616.
- Sun, Y., Yang, R., Zhong, J. G., Fang, F., Jiang, J. J., Liu, M. Y., and Lu, J. (2009). Aerosolised Surfactant Generated by a Novel Noninvasive Apparatus Reduced Acute Lung Injury in Rats. Crit. Care, 13:R31.
- Suresh, G. K., and Soll, R. F. (2002). Lung Surfactants for Neonatal Respiratory Distress Syndrome: Animal-Derived or Synthetic Agents? Paed. Drug., 4:485–492.
- Tal, A., Golan, H., Grauer, N., Aviram, M., Albin, D., and Quastel, M. R. (1996). Deposition Pattern of Radiolabeled Salbutamol Inhaled from a Metered-Dose Inhaler by Means of a Spacer with Mask in Young Children with Airway Obstruction. J. Pediatr., 128:479–484.
- Verder, H., Robertson, B., Greisen, G., Ebbesen, F., Albertsen, P., Lundstrom, K., and Jacobsen, T. (1994). Surfactant Therapy and Nasal Continuous Positive Airway Pressure for Newborns with Respiratory Distress Syndrome. Danish-Swedish Multicenter Study Group. New Engl. J. Med., 331:1051–1055.